Sources
FDA MedWatch
- Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication 3 days 8 hours old
- Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication 2 weeks 5 days old
- FDA Approves Labeling Changes that Include a Boxed Warning for Immune Effector Cell-associated Enterocolitis Following Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.) 3 weeks 3 days old
Quality and Safety in Health Care Journal
- Better bottom lines: patient satisfaction associated with addressing sexual and gender minority health 2 weeks 3 days old
- Addressing the risk of look-alike, sound-alike medication errors: bending metal or twisting arms? 2 weeks 3 days old
- Impact of hospitals LGBTQ+ inclusion efforts on patient satisfaction from 2016 to 2023: a retrospective longitudinal observational study 2 weeks 3 days old
